Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 
SAN DIEGO, Feb. 09, 2016 -- SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announced the appointment of Laurent Combredet as President and Chief Executive Officer.
"Laurent is a well respected and strategic leader in the aesthetics dermatology field and we are excited to leverage his leadership and experience to help take the company to the next level," said Faheem Hasnain, Chairman of the Board of Directors of SENTÉ. "Laurent is a tremendous addition to SENTÉ and I look forward to his strategic insight as we further position the company to be a major contender in the aesthetics industry.”
Mr. Combredet brings to SENTÉ nearly 20 years of commercial, operations and management experience in the dermatology and consumer products industry. Most recently, Mr. Combredet was General Manager at Allergan, Medical Dermatology and Skin Care Division (including the Skinmedica line of products), where he was responsible for the management of a $700M medical grade skin care business including international operations. Previous to Allergan, Mr. Combredet was Senior Category Leader, Health and Beauty for Amazon France where he held general management positions and full P&L ownership. Mr. Combredet has also held senior commercial and marketing roles with Johnson & Johnson, Neutrogena, Gap and Clairol. He holds a Bachelor of Arts degree from George Washington University and a Masters of Business Administration from Columbia Business School.
"I am thrilled and honored to be joining SENTÉ, a company with deep experience in biotechnology that is pioneering innovative science-based skin care products with proven patient benefits,” said Mr. Combredet, President and Chief Executive Officer of SENTÉ.
About SENTÉ:
SENTÉ is a privately held specialty aesthetics company leveraging its expertise and foundation in biotechnology to deliver novel, science-based skin care products. SENTÉ is a recognized leader in the development of innovative and targeted medical skincare products based on glycosaminoglycans. Founded in 2007 and based in San Diego, California, further information may be found at http://sentelabs.com/. SENTÉ products are available through its exclusive network of physicians and medically supervised spas.
Media Contact: Creative Media Marketing Danielle Hale [email protected] p: 212.979.8884 ext. 213
